Effect of arterial hypertension on chronic urticaria duration

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Franco NebioloGiovanni Rolla

Abstract

Reliable clinical or laboratory markers of chronic idiopathic urticaria (CIU) duration are not available. Angioedema, autologous serum skin test (ASST) results, and antithyroid antibodies have been inconsistently associated with longer urticaria duration. To investigate the association of clinical and laboratory parameters with CIU duration, including systemic hypertension, because activation of the coagulation cascade pathway may contribute to the pathogenesis of CIU. We performed a prospective study of a cohort of 228 consecutive adult patients with CIU of moderate to severe intensity referred to 2 outpatient allergy clinics and followed up for a 3- to 5-year period. The association of clinical and laboratory parameters (sex, atopy, markers of autoimmunity, antithyroid antibodies, positive ASST result, Helicobacter pylori infection, and hypertension) with urticaria duration was analyzed using semiparametric multivariable proportional hazards models (Cox regression) using remission as main outcome measure. Apart from systemic hypertension (hazard ratio, 0.71; 95% confidence interval, 0.53-0.95; P = .02), none of the considered parameters influenced CIU remission of our patients; 74% and 54% of our patients with and without hyp...Continue Reading

References

Apr 1, 1992·The British Journal of Dermatology·R J Barlow, M W Greaves
Apr 1, 1997·The Journal of Allergy and Clinical Immunology·L J TongA P Kaplan
May 8, 1999·The British Journal of Dermatology·R A SabroeM W Greaves
Aug 10, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·R ParslewP S Friedmann
Jan 19, 2002·The Journal of Allergy and Clinical Immunology·Yoko Kikuchi, Allen P Kaplan
May 6, 2003·Circulation Research·Georgina CollettAnn E Canfield
Jul 23, 2003·Current Pharmaceutical Design·Sunil Nadar, Gregory Y H Lip
Sep 1, 2005·Current Opinion in Allergy and Clinical Immunology·Javed Sheikh
Sep 1, 2005·Current Opinion in Allergy and Clinical Immunology·Stephen C Dreskin, Karen Y Andrews
May 23, 2006·Nature Medicine·Markus Huber-LangPeter A Ward
Jan 6, 2007·The Journal of Allergy and Clinical Immunology·Riccardo AseroMassimo Cugno
Apr 6, 2007·The Journal of Dermatology·Kanokvalai KulthananSumruay Pinkaew
Aug 30, 2007·Journal of Gastroenterology and Hepatology·Akiko ShiotaniKen Haruma
Jul 3, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Matt Morgan, David A Khan

❮ Previous
Next ❯

Citations

Nov 11, 2014·The World Allergy Organization Journal·Paul A Greenberger
Jun 7, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Heng-Wei ChangMao-Feng Sun
Aug 23, 2016·Primary Care·Van NguyenEcler Jaqua
Apr 4, 2013·International Archives of Allergy and Immunology·Rafael Rabelo-FilardiRégis A Campos
Dec 8, 2016·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P KolkhirM Metz
Mar 17, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·M Sánchez-BorgesM Maurer
Sep 19, 2019·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Ciara Jade Bansal, Amolak Singh Bansal
Oct 2, 2019·Clinical and Translational Allergy·Emek Kocatürk, Clive Grattan
Jun 7, 2019·Allergy, Asthma & Immunology Research·Taek Ki Min, Sarbjit S Saini
Dec 26, 2018·Journal of Immunology Research·Marco FolciEnrico Brunetta
Mar 30, 2019·Recent Patents on Inflammation & Allergy Drug Discovery·Kam L HonSteven K Loo
Aug 25, 2020·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Peter StepaniukAmin Kanani
Dec 10, 2020·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Iolanda Alen CoutinhoAna Todo Bom
Jul 6, 2021·The World Allergy Organization Journal·Mario Sánchez-BorgesJose Antonio Ortega Martell
Nov 23, 2021·Dermatology and Therapy·Maria-Magdalena BalpAlexander M Marsland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

The Journal of Allergy and Clinical Immunology
A P KaplanS I Katz
The Journal of Allergy and Clinical Immunology
S F NatbonyA P Kaplan
© 2022 Meta ULC. All rights reserved